Last year, LifeVantage Corp generated 95.33M USD for its biggest-performing segment, Protandim. The Americas made the largest contribution, accounting for 185.72M USD last year.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Protandim

Other

TrueScience

FY2025

FY2024

FY2023

FY2022

FY2021

Protandim

95.33M(41.71%)

104.14M(52.02%)

119.72M(56.10%)

135.62M(65.72%)

150.27M(68.25%)

Other

84.49M(36.97%)

39.78M(19.87%)

44.18M(20.70%)

47.87M(23.20%)

47.29M(21.48%)

TrueScience

48.71M(21.32%)

56.25M(28.10%)

49.49M(23.19%)

22.88M(11.09%)

22.62M(10.27%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

Americas

Asia/Pacific & Europe

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

Americas

185.72M(81.27%)

152.91M(76.39%)

155.36M(72.80%)

138.32M(67.03%)

154.66M(70.24%)

166.34M(71.41%)

150.84M(75.61%)

158.29M(76.64%)

138.12M(72.57%)

141.23M(66.00%)

133.05M(63.91%)

90.12M(71.42%)

Asia/Pacific & Europe

42.81M(18.73%)

47.26M(23.61%)

58.04M(27.20%)

68.04M(32.97%)

65.53M(29.76%)

66.58M(28.59%)

48.65M(24.39%)

48.25M(23.36%)

52.22M(27.43%)

72.74M(34.00%)

75.13M(36.09%)

36.06M(28.58%)